Market Analysis and Insights: Global Milk Allergy Clinical Trials Review Market

Cow’s milk allergy (CMA) is among the most common FA in early childhood, with an estimated prevalence of 2% to 3%. The mission for Milk Allergy Clinical Trials is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

Clinical trials are studies that determine if a new treatment is safe and effective in people. More food allergy clinical trials are underway today than ever before. These studies are the key to preventing dangerous food allergy reactions and finding a cure. Clinical trials are usually conducted at major medical centers. Funding for a study may come from a number of sources, including the federal government’s National Institutes of Health (NIH), nonprofit organizations such as FARE, and pharmaceutical or biotechnology companies.

Due to the COVID-19 pandemic, the global Milk Allergy Clinical Trials Review market size is estimated to be worth US$ 1022.4 million in 2022 and is forecast to a readjusted size of US$ 1244.5 million by 2029 with a CAGR of 2.8% during the forecast period 2023-2029. Fully considering the economic change by this health crisis, Skin Prick Tests accounting for % of the Milk Allergy Clinical Trials Review global market in 2022, is projected to value US$ million by 2029, growing at a revised % CAGR from 2023 to 2029. While Immediate Treatment segment is altered to an % CAGR throughout this forecast period.

The key companies of Milk Allergy Clinical Trials Review include Nestle, FrieslandCampina, Mead Johnson, Abbott, Danone SA and Perrigo Company, etc.

Global Milk Allergy Clinical Trials Review Scope and Market Size

The global Milk Allergy Clinical Trials Review market is segmented by company, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Milk Allergy Clinical Trials Review market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2018-2029.


Segment by Type


Skin Prick Tests

Blood Allergen Specific IgE Ttests

Oral Food Challenge

Food Elimination Diet


Segment by Application


Immediate Treatment

Management of CMPA

By Region

United States

Europe

China

Japan

Southeast Asia

India

Other Regions


By Company


Nestle

FrieslandCampina

Mead Johnson

Abbott

Danone SA

Perrigo Company